المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi pasteur msd ltd - neisseria meningitidis group c capsular polysaccharide; neisseria meningitidis group a capsular polysaccharide - powder and solvent for solution for injection

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

in vitro technologies pty ltd - ct793 - neisseria ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to neisseria bacteria in nucleic acid extracted from whole blood, cerebrospinal fluid, and nasopharyngeal swab specimens.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

speedx pty ltd - ct793 - neisseria ivds - ivds that are intended to be used in testing to provide information about infection or exposure to neisseria bacteria

المملكة العربية السعودية - الإنجليزية - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi pasteur - polysaccharide of neisseria meningitidis group a, polysaccharide of neisseria meningitidis group c - powder and solvent for suspension for injection - 50 , 50 µg

المملكة العربية السعودية - الإنجليزية - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi pasteur - polysaccharide of neisseria meningitidis group a, polysaccharide of neisseria meningitidis group c - powder and solvent for suspension for injection - 50 , 50 µg

كينيا - الإنجليزية - Pharmacy and Poisons Board

sanofi pasteur s.a. 2 avenue pont pasteur 69007 lyon france - neisseria meningitidis serogroup a c y and w-135… - solution for injection - each 0.5 ml dose contains 4 mcg of each … - bacterial vaccines: meningococcal vaccines

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

gsk vaccines s.r.l. - outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254), recombinant neisseria meningitidis group b fhbp fusion protein, recombinant neisseria meningitidis group b nada protein, recombinant neisseria meningitidis group b nhba fusion protein - meningitis, meningococcal - meningococcal vaccines - active immunisation against invasive disease caused by neisseria meningitidis serogroup-b strains.,

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - diphtheria toxoid protein; meningococcal (serogroup a) polysaccharide (monovalent conjugate); meningococcal (serogroup c) polysaccharide (monovalent conjugate); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate); meningococcal (serogroup y) polysaccharide (monovalent conjugate) - injection, solution - 48 microgram (diptheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio) - diphtheria toxoid protein 48 mcg/dose (0.5 ml) (diphtheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio); meningococcal (serogroup a) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup c) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup y) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

csl limited - corynebacterium diphtheriae; neisseria meningitidis group c oligosaccharide; neisseria -

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - meningococcal oligosaccharide - group c 10ug (conjugated with 5 mcg diphtheria crm 197 protein);   - suspension for injection - 0.5 ml - active: meningococcal oligosaccharide - group c 10ug (conjugated with 5 mcg diphtheria crm 197 protein)   excipient: aluminium phosphate sodium chloride water for injection - active immunisation of children from 6 weeks of age, adolescents and adults for the prevention of invasive disease caused by neisseria meningitidis serogroup c.